Sarepta Therapeutics, Inc.

LSE:0L35 Stock Report

Market Cap: US$3.9b

Sarepta Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

LSE:0L35 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
05 Dec 24SellUS$205,400Kathryn BoorIndividual1,636US$125.55
30 Aug 24SellUS$822,100Ian EstepanIndividual5,985US$137.36
16 Aug 24BuyUS$4,955,728Michael ChambersIndividual37,038US$134.66

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 0L35?
Owner TypeNumber of SharesOwnership Percentage
State or Government81,6320.0831%
Individual Insiders4,337,7954.41%
General Public5,072,2605.16%
Institutions88,785,34590.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 68.29% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.1%
BlackRock, Inc.
9,906,836US$396.2m-11.5%0.01%
9.44%
Capital Research and Management Company
9,274,116US$370.9m4.25%0.02%
9.19%
The Vanguard Group, Inc.
9,032,613US$361.2m-0.58%no data
4.14%
State Street Global Advisors, Inc.
4,068,472US$162.7m-0.03%0.01%
3.42%
Janus Henderson Group plc
3,364,845US$134.6m-22.3%0.05%
3.27%
Richard Barry
3,214,284US$128.5m1.02%no data
2.72%
Avoro Capital Advisors LLC
2,674,835US$107.0m4.67%1.56%
2.69%
Wellington Management Group LLP
2,646,619US$105.8m27.9%0.02%
2.38%
Farallon Capital Management, L.L.C.
2,341,424US$93.6m-18.3%0.5%
2.28%
T. Rowe Price Group, Inc.
2,236,239US$89.4m1.73%0.01%
1.94%
JP Morgan Asset Management
1,909,129US$76.3m10.4%0.01%
1.85%
Geode Capital Management, LLC
1,820,921US$72.8m6.71%no data
1.77%
Morgan Stanley, Investment Banking and Brokerage Investments
1,735,267US$69.4m145%0.01%
1.69%
Deutsche Asset & Wealth Management
1,663,573US$66.5m0.01%0.02%
1.47%
UBS Asset Management AG
1,446,458US$57.8m-18.7%0.01%
1.32%
Groupama Asset Management SA
1,300,000US$52.0m0%0.42%
1.32%
EcoR1 Capital, LLC
1,292,386US$51.7m67.8%2.96%
1.08%
Erste Asset Management GmbH
1,061,065US$42.4m70.3%0.28%
1.06%
Norges Bank Investment Management
1,038,861US$41.5m0%no data
0.95%
Pictet Asset Management Limited
937,023US$37.5m-10.4%0.02%
0.92%
Casdin Capital, LLC
900,783US$36.0m-16.1%2.8%
0.92%
Deep Track Capital, LP
899,731US$36.0m0%1.18%
0.81%
Camber Capital Management LP
800,000US$32.0m-20%1.99%
0.79%
BNY Asset Management
773,502US$30.9m-63.6%0.01%
0.78%
Northern Trust Global Investments
769,817US$30.8m-4.19%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/21 03:49
End of Day Share Price 2025/05/21 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sarepta Therapeutics, Inc. is covered by 54 analysts. 22 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Brian SkorneyBaird
Huidong WangBarclays
Yun ZhongBerenberg